Sondel PM - Search Results

1

Lymphokines and cytokines as cancer treatment. Immunotherapy realized.

Borden EC, Sondel PM. Borden EC, et al. Among authors: sondel pm. Cancer. 1990 Feb 1;65(3 Suppl):800-14. doi: 10.1002/1097-0142(19900201)65:3+<800::aid-cncr2820651328>3.0.co;2-y. Cancer. 1990. PMID: 2406003 Review.

2

Effects of interleukin-2 (IL-2) on human plasma lipid, lipoprotein, and C-reactive protein.

Rosenzweig IB, Wiebe DA, Hank JA, Albers JJ, Adolphson JL, Borden E, Shrago ES, Sondel PM. Rosenzweig IB, et al. Among authors: sondel pm. Biotherapy. 1990;2(3):193-8. doi: 10.1007/BF02173519. Biotherapy. 1990. PMID: 1698421 Clinical Trial.

3

Implications of interferon-induced tryptophan catabolism in cancer, auto-immune diseases and AIDS.

Brown RR, Ozaki Y, Datta SP, Borden EC, Sondel PM, Malone DG. Brown RR, et al. Among authors: sondel pm. Adv Exp Med Biol. 1991;294:425-35. doi: 10.1007/978-1-4684-5952-4_39. Adv Exp Med Biol. 1991. PMID: 1722946 Review.

4

Immunological effects of levamisole in vitro.

Schiller JH, Lindstrom M, Witt PL, Hank JA, Mahvi D, Wagner RJ, Sondel P, Borden EC. Schiller JH, et al. J Immunother (1991). 1991 Oct;10(5):297-306. doi: 10.1097/00002371-199110000-00001. J Immunother (1991). 1991. PMID: 1790137

5

Depressed in vitro T cell responses concomitant with augmented interleukin-2 responses by lymphocytes from cancer patients following in vivo treatment with interleukin-2.

Hank JA, Sosman JA, Kohler PC, Bechhofer R, Storer B, Sondel PM. Hank JA, et al. Among authors: sondel pm. J Biol Response Mod. 1990 Feb;9(1):5-14. J Biol Response Mod. 1990. PMID: 2181071 Clinical Trial.

6

Prospects for interleukin-2 therapy in hematologic malignant neoplasms.

Malkovska V, Sondel PM. Malkovska V, et al. Among authors: sondel pm. J Natl Cancer Inst Monogr. 1990;(10):69-72. J Natl Cancer Inst Monogr. 1990. PMID: 2189478 Review.

7

The influence of autologous lymphokine-activated killer cell infusions on the toxicity and antitumor effect of repetitive cycles of interleukin-2.

Albertini MR, Sosman JA, Hank JA, Moore KH, Borchert A, Schell K, Kohler PC, Bechhofer R, Storer B, Sondel PM. Albertini MR, et al. Among authors: sondel pm. Cancer. 1990 Dec 15;66(12):2457-64. doi: 10.1002/1097-0142(19901215)66:12<2457::aid-cncr2820661203>3.0.co;2-l. Cancer. 1990. PMID: 2249185 Clinical Trial.

8

Addition of interleukin-2 in vitro augments detection of lymphokine-activated killer activity generated in vivo.

Hank JA, Weil-Hillman G, Surfus JE, Sosman JA, Sondel PM. Hank JA, et al. Among authors: sondel pm. Cancer Immunol Immunother. 1990;31(1):53-9. doi: 10.1007/BF01742496. Cancer Immunol Immunother. 1990. PMID: 2306756 Free PMC article.

9

The appearance of hypodense eosinophils during interleukin-2 treatment.

Sedgwick JB, Frick WE, Sondel PM, Hank JA, Borden E, Busse WW. Sedgwick JB, et al. Among authors: sondel pm. J Allergy Clin Immunol. 1990 Mar;85(3):557-66. doi: 10.1016/0091-6749(90)90093-j. J Allergy Clin Immunol. 1990. PMID: 2312991

10

Augmentation of antibody dependent cell mediated cytotoxicity following in vivo therapy with recombinant interleukin 2.

Hank JA, Robinson RR, Surfus J, Mueller BM, Reisfeld RA, Cheung NK, Sondel PM. Hank JA, et al. Among authors: sondel pm. Cancer Res. 1990 Sep 1;50(17):5234-9. Cancer Res. 1990. PMID: 2386933

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

382 results

Search Page

Filters